Merit Medical Systems, Inc. (NASDAQ:MMSI) Shares Bought by GAMMA Investing LLC

GAMMA Investing LLC lifted its position in shares of Merit Medical Systems, Inc. (NASDAQ:MMSI) by 14.7% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 1,494 shares of the medical instruments supplier’s stock after purchasing an additional 191 shares during the quarter. GAMMA Investing LLC’s holdings in Merit Medical Systems were worth $144,000 as of its most recent SEC filing.

Other institutional investors have also recently made changes to their positions in the company. USA Financial Formulas acquired a new stake in Merit Medical Systems during the third quarter valued at $59,000. National Bank of Canada FI purchased a new stake in shares of Merit Medical Systems during the 2nd quarter worth about $77,000. Farther Finance Advisors LLC grew its position in shares of Merit Medical Systems by 32.7% during the 3rd quarter. Farther Finance Advisors LLC now owns 1,056 shares of the medical instruments supplier’s stock valued at $104,000 after acquiring an additional 260 shares during the period. Canada Pension Plan Investment Board acquired a new stake in shares of Merit Medical Systems during the 2nd quarter valued at about $112,000. Finally, Harvest Fund Management Co. Ltd purchased a new position in shares of Merit Medical Systems in the 3rd quarter valued at about $120,000. 99.66% of the stock is owned by hedge funds and other institutional investors.

Insider Buying and Selling

In other Merit Medical Systems news, CFO Raul Jr. Parra sold 29,646 shares of the firm’s stock in a transaction on Tuesday, November 5th. The stock was sold at an average price of $98.02, for a total value of $2,905,900.92. Following the completion of the sale, the chief financial officer now directly owns 16,361 shares of the company’s stock, valued at $1,603,705.22. This trade represents a 64.44 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director F. Ann Millner sold 12,500 shares of Merit Medical Systems stock in a transaction on Friday, November 15th. The stock was sold at an average price of $101.55, for a total value of $1,269,375.00. Following the transaction, the director now owns 32,391 shares in the company, valued at approximately $3,289,306.05. This represents a 27.85 % decrease in their position. The disclosure for this sale can be found here. 3.70% of the stock is currently owned by company insiders.

Merit Medical Systems Stock Performance

NASDAQ:MMSI opened at $98.14 on Friday. The company has a market cap of $5.72 billion, a P/E ratio of 48.11, a P/E/G ratio of 2.55 and a beta of 0.85. Merit Medical Systems, Inc. has a twelve month low of $70.70 and a twelve month high of $108.07. The company’s 50-day moving average price is $101.12 and its 200-day moving average price is $95.24. The company has a current ratio of 5.36, a quick ratio of 3.82 and a debt-to-equity ratio of 0.57.

Merit Medical Systems (NASDAQ:MMSI) last released its earnings results on Wednesday, October 30th. The medical instruments supplier reported $0.86 earnings per share for the quarter, topping analysts’ consensus estimates of $0.80 by $0.06. The business had revenue of $339.85 million for the quarter, compared to analyst estimates of $334.60 million. Merit Medical Systems had a net margin of 9.05% and a return on equity of 15.61%. The business’s revenue was up 7.8% on a year-over-year basis. During the same period last year, the company posted $0.75 EPS. On average, sell-side analysts forecast that Merit Medical Systems, Inc. will post 3.36 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

A number of equities analysts have issued reports on the company. Wells Fargo & Company upgraded Merit Medical Systems from an “equal weight” rating to an “overweight” rating and increased their price target for the stock from $103.00 to $120.00 in a research report on Wednesday, December 11th. StockNews.com cut shares of Merit Medical Systems from a “buy” rating to a “hold” rating in a research note on Sunday, November 3rd. Barrington Research restated an “outperform” rating and set a $114.00 price objective on shares of Merit Medical Systems in a research report on Monday, December 23rd. Raymond James increased their price objective on shares of Merit Medical Systems from $105.00 to $110.00 and gave the company an “outperform” rating in a report on Tuesday, December 31st. Finally, Robert W. Baird boosted their target price on shares of Merit Medical Systems from $107.00 to $109.00 and gave the stock an “outperform” rating in a research note on Thursday, October 31st. Two analysts have rated the stock with a hold rating, nine have issued a buy rating and one has assigned a strong buy rating to the company’s stock. According to data from MarketBeat.com, Merit Medical Systems currently has a consensus rating of “Moderate Buy” and an average target price of $107.70.

Merit Medical Systems Profile

Merit Medical Systems, Inc designs, develops, manufactures, and markets single-use medical products for interventional, diagnostic, and therapeutic procedures in the United States and internationally. It operates in two segments, Cardiovascular and Endoscopy. The company provides micropuncture kits, angiographic needles, sheaths, guide wires, and safety products; peripheral intervention, including angiography, drainage, delivery systems, and embolotherapy products; spine products, such as vertebral augmentation, radiofrequency ablation, and bone biopsy systems; oncology products; and cardiac intervention products, such as access, angiography, electrophysiology and cardiac rhythm management, fluid management, hemodynamic monitoring, hemostasis, and intervention to treat various heart conditions.